Boehringer Ingelheim Starts Phase II Trial of Trip...
Category : Clinical Trial Update 17 July 2026Company Expands Obesity Pipeline with New Investigational Therapy Boehringer Ingelheim has starte...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Atea Pharmaceuticals Begins First Human Trial of A...
Category : Clinical Trial Update 17 July 2026Atea Advances a New Oral Antiviral Candidate Into Clinical Testing Atea Pharmaceuticals has start...
Lingke Pharmaceuticals completes patient enrolment...
Category : Clinical Trial Update 16 July 2026Lingke Pharmaceutical (Zhejiang) Co., Ltd. (Lingke Pharmaceutical), a clinical-stage innovative drug...
US FDA clears Atrium Therapeutics’ IND application...
Category : Clinical Trial Update 16 July 2026Atrium Therapeutics, Inc., a biopharmaceutical company dedicated to delivering RNA therapeutics to t...
Celea Therapeutics Doses First Patient in Global P...
Category : Clinical Trial Update 15 July 2026Celea Therapeutics has announced that the first patient has been dosed in its global Phase 3 SURPASS...
Latest Newsletter Post
-
Atea Pharmaceuticals Begins First H..
17 July 2026
-
Boehringer Ingelheim Starts Phase I..
17 July 2026
-
US FDA clears Atrium Therapeutics’..
16 July 2026
-
Lingke Pharmaceuticals completes pa..
16 July 2026
-
Skyhawk Therapeutics Expands Global..
15 July 2026
